Department of Health and Social Care’s UK Vaccine Network funding awarded to Pirbright to aid Nipah virus vaccine development

Pirbright researchers have been awarded £389,089 to develop a Nipah virus vaccine that could protect pigs and prevent disease in humans. In collaboration with the Friedrich-Loeffler-Institut, Germany, they will genetically engineer the vaccine so it can also induce protection against Nipah virus.